R

Relay Therapeutics, Inc.

RLAY Nasdaq Healthcare · Biological Products, (No Diagnostic Substances) Cambridge, MA relaytx.com
$20.52
Mkt Cap 4.50B

Biopharmaceutical company that uses protein-motion-based drug discovery technology to develop new medicines; no approved products yet.

relaytx.com ↗Summary by The Compound Family, based on the company’s own website
—
/100 Overall
Calculating score…
Running full analysis
Ready to value this company?
Run a full DCF model with Monte Carlo simulation.
Run DCF Valuation →
📊 Key Metrics
Loading full analysis…
REVENUE TTM
$10.3M
-28.6% CAGR
Running full 6-factor analysis…